Company · CIK 1830749

# Achilles Therapeutics plc

| CIK | [1830749](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001830749) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | X0 |
| Business address | United Kingdom |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2022-03-01 |

## Offerings

 2 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-268239 | Shelf Effective | 2022-11-08 | 2025-03-11 | 3 |
| 333-253735 | IPO Final prospectus | 2021-03-01 | 2021-03-31 | 6 |

## Filings

 10

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-03-11 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1830749/999999999525000635/9999999995-25-000635-index.htm) Declared effective | 333-268239 | 9999999995-25-000635 |
| 2022-11-17 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1830749/999999999522003336/9999999995-22-003336-index.htm) Declared effective | 333-268239 | 9999999995-22-003336 |
| 2022-11-08 | [F-3](https://www.sec.gov/Archives/edgar/data/1830749/000119312522279779/0001193125-22-279779-index.htm) Shelf registered | 333-268239 | 0001193125-22-279779 |
| 2021-03-31 | [424B4](https://www.sec.gov/Archives/edgar/data/1830749/000119312521102495/0001193125-21-102495-index.htm) Final prospectus | 333-253735 | 0001193125-21-102495 |
| 2021-03-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1830749/999999999521001207/9999999995-21-001207-index.htm) Declared effective | 333-253735 | 9999999995-21-001207 |
| 2021-03-29 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1830749/000119312521098251/0001193125-21-098251-index.htm) Amendment | 333-253735 | 0001193125-21-098251 |
| 2021-03-25 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1830749/000119312521093358/0001193125-21-093358-index.htm) Amendment | 333-253735 | 0001193125-21-093358 |
| 2021-03-10 | [F-1/A](https://www.sec.gov/Archives/edgar/data/1830749/000119312521076206/0001193125-21-076206-index.htm) Amendment | 333-253735 | 0001193125-21-076206 |
| 2021-03-01 | [F-1](https://www.sec.gov/Archives/edgar/data/1830749/000119312521063774/0001193125-21-063774-index.htm) Registration filed | 333-253735 | 0001193125-21-063774 |
| 2020-11-27 | [DRS](https://www.sec.gov/Archives/edgar/data/1830749/000095012320012393/0000950123-20-012393-index.htm) Draft made public | 377-03834 | 0000950123-20-012393 |

[All filings of this company](https://equitycapital.markets/filings?cik=1830749) · [CSV](https://equitycapital.markets/filings.csv?cik=1830749)

---
Source page: https://equitycapital.markets/company/1830749 · Data: U.S. SEC EDGAR · CC BY 4.0